The pharmaceutical industry is known for sugar coating tough medications to make it easy for people to accept and ingest. Maybe that is what is needed here, some tough medication, to eradicate the problem so the company can survive and recover. Only time will tell whether the company and shareholders are prepared to take the medication or whether they want to reject it and sink in to the financial abyss they have been sitting on the edge of for quite some time now.
If what you are saying is correct and in the spirit of the discussion using medical analogies one might offer the current incumbents seek this to become a cadaver (a defunct unlisted public company) so they can attempt to create a frankenstein (something in Fiji perhaps) of their own liking.
Either way the shareholders have some tough choices ahead of them and maybe some sugar coating is what is actually needed so long as the alternatives are not on falsehoods and a repeat of history.
